CVM CEL SCI CORP
NYSE · SEC CIK 725363 · EDGAR
- Bought, last 12 months
- $867.0K 5 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 121 since 2021-07-01, latest 2026-08-26 08:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| KERSTEN GEERT R | CEO, Dir | $867.0K | — |
| TALOR EYAL | CSO | — | — |
| PRICHEP PATRICIA B | CFO | — | — |
Transactions 83
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-26 08:32 | 2026-08-25 | CVM | KERSTEN GEERT R | CEO, Dir | P - Purchase | $1.38 | +100.0K | 316.1K | +46% | +$138.0K | |
| 2026-07-01 08:40 | 2026-06-30 | CVM | TALOR EYAL | CSO | A - Grant | $1.04 | +2,307 | 9,318 | +33% | +$2,399 | |
| 2026-07-01 08:37 | 2026-06-30 | CVM | PRICHEP PATRICIA B | CFO | A - Grant | $1.04 | +4,125 | 17.5K | +31% | +$4,290 | |
| 2026-07-01 08:33 | 2026-06-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $1.04 | +5,192 | 216.1K | +2% | +$5,400 | |
| I | 2026-05-18 08:03 | 2026-05-14 | CVM | KERSTEN GEERT R | CEO, Dir | P - Purchase | $1.20 | +300.0K | 311.5K | +2,598% | +$360.0K |
| 2026-05-14 08:56 | 2026-05-13 | CVM | KERSTEN GEERT R | CEO, Dir | P - Purchase | $1.19 | +100.0K | 222.5K | +82% | +$119.0K | |
| 2026-04-01 07:08 | 2026-03-31 | CVM | TALOR EYAL | CSO | A - Grant | $3.21 | +747 | 7,011 | +12% | +$2,398 | |
| 2026-04-01 07:03 | 2026-03-31 | CVM | PRICHEP PATRICIA B | CFO | A - Grant | $3.21 | +1,336 | 13.4K | +11% | +$4,289 | |
| 2026-04-01 06:59 | 2026-03-31 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $3.21 | +1,682 | 122.5K | +1% | +$5,399 | |
| 2026-01-26 | 2026-01-22 | CVM | KERSTEN GEERT R | CEO, Dir | P - Purchase | $5.26 | +38.0K | 120.8K | +46% | +$200.0K | |
| 2026-01-05 | 2025-12-31 | CVM | TALOR EYAL | CSO | A - Grant | $5.26 | +456 | 6,264 | +8% | +$2,399 | |
| 2026-01-05 | 2025-12-31 | CVM | PRICHEP PATRICIA B | CFO | A - Grant | $5.26 | +815 | 12.0K | +7% | +$4,287 | |
| 2026-01-05 | 2025-12-31 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $5.26 | +998 | 82.8K | +1% | +$5,249 | |
| 2025-12-05 | 2025-12-04 | CVM | KERSTEN GEERT R | CEO, Dir | P - Purchase | $5.96 | +8,389 | 81.8K | +11% | +$50.0K | |
| 2025-10-02 | 2025-09-30 | CVM | TALOR EYAL | CSO | A - Grant | $9.20 | +260 | 5,808 | +5% | +$2,392 | |
| 2025-10-02 | 2025-09-30 | CVM | PRICHEP PATRICIA B | CFO | A - Grant | $9.20 | +466 | 11.2K | +4% | +$4,287 | |
| 2025-10-02 | 2025-09-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $9.20 | +570 | 73.4K | +0.8% | +$5,244 | |
| 2025-07-29 | 2025-07-25 | CVM | Watson Robert Eugene | Dir | P - Purchase | $6.85 | +2,919 | 3,733 | +359% | +$20.0K | |
| 2025-07-28 | 2025-07-25 | CVM | KERSTEN GEERT R | CEO, Dir | P - Purchase | $6.85 | +29.2K | 72.8K | +67% | +$200.0K | |
| 2025-07-01 | 2025-06-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $2.29 | +2,292 | 43.6K | +6% | +$5,249 | |
| 2025-07-01 | 2025-06-30 | CVM | TALOR EYAL | CSO | A - Grant | $2.29 | +1,048 | 5,548 | +23% | +$2,400 | |
| 2025-07-01 | 2025-06-30 | CVM | PRICHEP PATRICIA B | CFO | A - Grant | $2.29 | +1,873 | 10.7K | +21% | +$4,289 | |
| 2025-04-01 | 2025-03-31 | CVM | PRICHEP PATRICIA B | CFO | A - Grant | $0.23 | +15.4K | 266.2K | +6% | +$3,549 | |
| 2025-04-01 | 2025-03-31 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $0.23 | +22.8K | 1.24M | +2% | +$5,241 | |
| 2025-04-01 | 2025-03-31 | CVM | TALOR EYAL | CSO | A - Grant | $0.23 | +10.4K | 135.0K | +8% | +$2,396 | |
| 2025-01-02 | 2024-12-31 | CVM | PRICHEP PATRICIA B | Chief Financial, Ops | A - Grant | $0.4 | +10.7K | 250.8K | +4% | +$4,291 | |
| 2025-01-02 | 2024-12-31 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $0.4 | +12.9K | 1.22M | +1% | +$5,176 | |
| 2025-01-02 | 2024-12-31 | CVM | TALOR EYAL | CSO | A - Grant | $0.4 | +6,001 | 124.6K | +5% | +$2,400 | |
| 2024-10-01 | 2024-09-30 | CVM | PRICHEP PATRICIA B | SVP of Ops | A - Grant | $1.06 | +4,047 | 240.1K | +2% | +$4,290 | |
| 2024-10-01 | 2024-09-30 | CVM | TALOR EYAL | CSO | A - Grant | $1.06 | +2,264 | 118.6K | +2% | +$2,400 | |
| 2024-10-01 | 2024-09-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $1.06 | +4,882 | 1.20M | +0.4% | +$5,175 | |
| 2024-07-01 | 2024-06-28 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $1.16 | +3,698 | 236.0K | +2% | +$4,290 | |
| 2024-07-01 | 2024-06-28 | CVM | TALOR EYAL | CSO | A - Grant | $1.16 | +2,068 | 116.3K | +2% | +$2,399 | |
| 2024-07-01 | 2024-06-28 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $1.16 | +4,461 | 1.20M | +0.4% | +$5,175 | |
| 2024-05-10 | 2024-05-08 | CVM | Watson Robert Eugene | Dir | P - Purchase | $1.39 | +20.0K | 24.4K | +451% | +$27.8K | |
| 2024-05-09 | 2024-05-08 | CVM | KERSTEN GEERT R | CEO, Dir | P - Purchase | $1.39 | +30.0K | 1.20M | +3% | +$41.7K | |
| 2024-05-09 | 2024-05-08 | CVM | PRICHEP PATRICIA B | SVP | P - Purchase | $1.39 | +8,000 | 232.3K | +4% | +$11.1K | |
| 2024-04-02 | 2024-03-29 | CVM | TALOR EYAL | CSO | A - Grant | $1.91 | +1,256 | 114.3K | +1% | +$2,399 | |
| 2024-04-02 | 2024-03-29 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $1.91 | +2,246 | 224.3K | +1% | +$4,290 | |
| 2024-04-02 | 2024-03-29 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $1.91 | +2,709 | 1.17M | +0.2% | +$5,174 | |
| 2024-01-02 | 2023-12-29 | CVM | TALOR EYAL | CSO | A - Grant | $2.72 | +882 | 113.0K | +0.8% | +$2,399 | |
| 2024-01-02 | 2023-12-29 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $2.72 | +1,577 | 222.1K | +0.7% | +$4,289 | |
| 2024-01-02 | 2023-12-29 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $2.72 | +1,819 | 1.16M | +0.2% | +$4,948 | |
| 2023-10-03 | 2023-09-29 | CVM | TALOR EYAL | CSO | A - Grant | $1.25 | +1,920 | 112.1K | +2% | +$2,400 | |
| 2023-10-03 | 2023-09-29 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $1.25 | +3,960 | 1.16M | +0.3% | +$4,950 | |
| 2023-10-03 | 2023-09-29 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $1.25 | +3,432 | 220.5K | +2% | +$4,290 | |
| 2023-07-03 | 2023-06-30 | CVM | TALOR EYAL | CSO | A - Grant | $2.41 | +995 | 110.2K | +0.9% | +$2,398 | |
| 2023-07-03 | 2023-06-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $2.41 | +2,053 | 1.16M | +0.2% | +$4,948 | |
| 2023-07-03 | 2023-06-30 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $2.41 | +1,780 | 217.1K | +0.8% | +$4,290 | |
| 2023-04-06 | 2023-03-31 | CVM | TALOR EYAL | CSO | A - Grant | $2.32 | +1,034 | 109.2K | +1.0% | +$2,399 | |
| 2023-04-06 | 2023-03-31 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $2.32 | +1,849 | 215.3K | +0.9% | +$4,290 | |
| 2023-04-06 | 2023-03-31 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $2.32 | +2,133 | 1.15M | +0.2% | +$4,949 | |
| 2023-01-03 | 2022-12-30 | CVM | TALOR EYAL | CSO | A - Grant | $2.35 | +1,021 | 108.2K | +1.0% | +$2,399 | |
| 2023-01-03 | 2022-12-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $2.35 | +1,851 | 1.15M | +0.2% | +$4,350 | |
| 2023-01-03 | 2022-12-30 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $2.35 | +1,825 | 213.4K | +0.9% | +$4,289 | |
| 2022-10-03 | 2022-09-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $3.09 | +1,407 | 1.15M | +0.1% | +$4,348 | |
| 2022-10-03 | 2022-09-30 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $3.09 | +1,388 | 211.6K | +0.7% | +$4,289 | |
| 2022-10-03 | 2022-09-30 | CVM | TALOR EYAL | CSO | A - Grant | $3.09 | +776 | 107.2K | +0.7% | +$2,398 | |
| 2022-10-03 | 2022-09-30 | CVM | ZIMMERMAN DANIEL H | SVP | A - Grant | $3.09 | +1,266 | 120.2K | +1% | +$3,912 | |
| 2022-07-05 | 2022-06-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $4.50 | +966 | 1.15M | +0.1% | +$4,347 | |
| 2022-07-05 | 2022-06-30 | CVM | ZIMMERMAN DANIEL H | SVP | A - Grant | $4.50 | +876 | 119.0K | +0.7% | +$3,942 | |
| 2022-07-05 | 2022-06-30 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $4.50 | +953 | 210.2K | +0.5% | +$4,288 | |
| 2022-07-05 | 2022-06-30 | CVM | TALOR EYAL | CSO | A - Grant | $4.50 | +533 | 106.4K | +0.5% | +$2,398 | |
| 2022-03-31 | 2022-03-31 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $3.93 | +1,091 | 209.3K | +0.5% | +$4,288 | |
| 2022-03-31 | 2022-03-31 | CVM | ZIMMERMAN DANIEL H | SVP | A - Grant | $3.93 | +1,006 | 118.1K | +0.9% | +$3,954 | |
| 2022-03-31 | 2022-03-31 | CVM | TALOR EYAL | CSO | A - Grant | $3.93 | +610 | 105.8K | +0.6% | +$2,397 | |
| 2022-03-31 | 2022-03-31 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $3.93 | +1,106 | 1.15M | +0.1% | +$4,347 | |
| 2022-01-03 | 2021-12-31 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $7.10 | +612 | 1.15M | +0.1% | +$4,345 | |
| 2022-01-03 | 2021-12-31 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $7.10 | +604 | 208.2K | +0.3% | +$4,288 | |
| 2022-01-03 | 2021-12-31 | CVM | TALOR EYAL | CSO | A - Grant | $7.10 | +338 | 105.2K | +0.3% | +$2,400 | |
| 2022-01-03 | 2021-12-31 | CVM | ZIMMERMAN DANIEL H | SVP | A - Grant | $7.10 | +557 | 117.1K | +0.5% | +$3,955 | |
| 2021-10-21 | 2021-10-19 | CVM | TALOR EYAL | CSO | S - Sale | $11.25 | -15.0K | 104.9K | -13% | -$168.8K | |
| 2021-10-04 | 2021-09-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $10.99 | +395 | 1.15M | +0.0% | +$4,341 | |
| 2021-10-04 | 2021-09-30 | CVM | TALOR EYAL | CSO | A - Grant | $10.99 | +218 | 119.9K | +0.2% | +$2,396 | |
| 2021-10-04 | 2021-09-30 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $10.99 | +372 | 207.6K | +0.2% | +$4,088 | |
| 2021-10-04 | 2021-09-30 | CVM | ZIMMERMAN DANIEL H | SVP | A - Grant | $10.99 | +343 | 116.5K | +0.3% | +$3,770 | |
| I | 2021-07-07 | 2021-07-06 | CVM | KERSTEN GEERT R | CEO, Dir | P - Purchase | $8.00 | +25.0K | 1.15M | +2% | +$200.0K |
| 2021-07-07 | 2021-07-06 | CVM | BAILLAVOINE BRUNO JEAN-MARIE | Dir | P - Purchase | $8.00 | +1,250 | 5,973 | +26% | +$10.0K | |
| 2021-07-07 | 2021-07-06 | CVM | Watson Robert Eugene | Dir | P - Purchase | $8.00 | +1,250 | 4,431 | +39% | +$10.0K | |
| 2021-07-01 | 2021-06-30 | CVM | KERSTEN GEERT R | CEO, Dir | A - Grant | $8.68 | +501 | 1.12M | +0.0% | +$4,349 | |
| 2021-07-01 | 2021-06-30 | CVM | PRICHEP PATRICIA B | SVP | A - Grant | $8.68 | +471 | 207.2K | +0.2% | +$4,088 | |
| 2021-07-01 | 2021-06-30 | CVM | TALOR EYAL | CSO | A - Grant | $8.68 | +276 | 119.7K | +0.2% | +$2,396 | |
| 2021-07-01 | 2021-06-30 | CVM | ZIMMERMAN DANIEL H | SVP | A - Grant | $8.68 | +435 | 116.2K | +0.4% | +$3,776 |
Purchase Sale Sale after option exercise All abbreviations